BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22832492)

  • 21. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.
    Etchin J; Sun Q; Kentsis A; Farmer A; Zhang ZC; Sanda T; Mansour MR; Barcelo C; McCauley D; Kauffman M; Shacham S; Christie AL; Kung AL; Rodig SJ; Chook YM; Look AT
    Leukemia; 2013 Jan; 27(1):66-74. PubMed ID: 22847027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.
    von Knethen A; Tzieply N; Jennewein C; Brüne B
    J Cell Sci; 2010 Jan; 123(Pt 2):192-201. PubMed ID: 20026644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.
    Pathria G; Garg B; Wagner C; Garg K; Gschaider M; Jalili A; Wagner SN
    J Invest Dermatol; 2016 Jan; 136(1):264-74. PubMed ID: 26763446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain.
    Langer K; Dian C; Rybin V; Müller CW; Petosa C
    PLoS One; 2011 Feb; 6(2):e17011. PubMed ID: 21364925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo.
    Daelemans D; Costes SV; Lockett S; Pavlakis GN
    Mol Cell Biol; 2005 Jan; 25(2):728-39. PubMed ID: 15632073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
    Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
    Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
    Azimi A; Tuominen R; Costa Svedman F; Caramuta S; Pernemalm M; Frostvik Stolt M; Kanter L; Kharaziha P; Lehtiö J; Hertzman Johansson C; Höiom V; Hansson J; Egyhazi Brage S
    Cell Death Dis; 2017 Aug; 8(8):e3029. PubMed ID: 29048432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
    Booth DS; Cheng Y; Frankel AD
    Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
    Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
    PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7.
    Dorfman J; Macara IG
    Mol Biol Cell; 2008 Apr; 19(4):1614-26. PubMed ID: 18256292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
    Kojima K; Kornblau SM; Ruvolo V; Dilip A; Duvvuri S; Davis RE; Zhang M; Wang Z; Coombes KR; Zhang N; Qiu YH; Burks JK; Kantarjian H; Shacham S; Kauffman M; Andreeff M
    Blood; 2013 May; 121(20):4166-74. PubMed ID: 23564911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nucleoporin-like protein NLP1 (hCG1) promotes CRM1-dependent nuclear protein export.
    Waldmann I; Spillner C; Kehlenbach RH
    J Cell Sci; 2012 Jan; 125(Pt 1):144-54. PubMed ID: 22250199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importins and exportins as therapeutic targets in cancer.
    Mahipal A; Malafa M
    Pharmacol Ther; 2016 Aug; 164():135-43. PubMed ID: 27113410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atomic basis of CRM1-cargo recognition, release and inhibition.
    Fung HY; Chook YM
    Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Crm de la crème of mitosis.
    Clarke PR
    Nat Cell Biol; 2005 Jun; 7(6):551-2. PubMed ID: 15928702
    [No Abstract]   [Full Text] [Related]  

  • 36. Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis.
    Chan KS; Wong CH; Huang YF; Li HY
    Cell Death Dis; 2010 Jul; 1(7):e57. PubMed ID: 21364662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.
    Stauber RH; Rabenhorst U; Rekik A; Engels K; Bier C; Knauer SK
    Traffic; 2006 Nov; 7(11):1461-72. PubMed ID: 16984408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1.
    Santiago A; Li D; Zhao LY; Godsey A; Liao D
    Mol Biol Cell; 2013 Sep; 24(17):2739-52. PubMed ID: 23825024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.
    Sakakibara K; Saito N; Sato T; Suzuki A; Hasegawa Y; Friedman JM; Kufe DW; Vonhoff DD; Iwami T; Kawabe T
    Blood; 2011 Oct; 118(14):3922-31. PubMed ID: 21841164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.